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Tweetable: Study reports on women’s views of consent to research in an obstetric 30 
emergency  31 
Abstract  32 
Objective: The WOMAN Trial was the first in the UK to use the option of waiver of informed 33 
consent at the time of an obstetric emergency. This qualitative study aimed to investigate 34 
participants’ views of the acceptability of the recruitment methods used.  35 
Design: Qualitative study using in-depth interviews with women who did and did not give 36 
consent at the time of their recruitment to the WOMAN Trial.  37 
Setting:  Highest UK recruitment site for the WOMAN Trial (129/569). Interviews were 38 
conducted in participants’ homes. 39 
Population:   40 of the 129 women who were recruited to the WOMAN Trial at one UK site 40 
were invited to take part, 15 women were interviewed.  41 
Methods: Qualitative, interview study  42 
Main outcome measures Facilitators and barriers to successful recruitment during obstetric 43 
emergencies. Guidance for future researchers.  44 
Results: Findings revealed that what is important is not so much the consent process used 45 
or a signature on a form, but the way in which consent is obtained. Clinicians who 46 
successfully negotiate consent to research during childbirth emergencies engage in a 47 
“humane choreography” of words and actions. This emphasises the importance of prompt 48 
decision making and treatment, whilst respecting the woman’s personal situation and 49 
experience.  50 
Conclusions 51 
Our findings do not support a single pathway to consent in the context of an obstetric 52 
emergency. Women understand that consent to research in an emergency is complex. 53 
Clinicians’ skills in considering the clinical, ethical and emotional aspects within the context 54 
of the clinical emergency can hamper or promote women’s satisfaction.  55 
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Introduction  62 
Debate about consent to research during the vulnerable time of childbirth and childbirth 63 
emergencies is longstanding.1-5 Guidelines for the conduct of maternity research where time 64 
is critical recognise how informing all women about potential emergencies in advance may 65 
create unnecessary anxiety.4 However giving information and gaining consent at the time 66 
can delay potentially lifesaving treatments.5 The ideal of valid, informed consent becomes 67 
unworkable in some obstetric emergencies and the developments of flexible research 68 
protocols that acknowledge this are welcomed. Understanding the views and experiences of 69 
those directly involved is paramount. Deferred consent precedents have been set and 70 
evaluated in the context of emergency medicine6-8 and paediatric trials.9-10 However, in 71 
obstetrics, deferred consent had only been explored hypothetically.11 The use of a verbal 72 
consent within emergency peripartum trials is associated with professional anxiety.12 The 73 
completion of the WOMAN Trial presented a unique opportunity to investigate the views of 74 
women who had lived through this experience. 75 
 76 
The WOMAN Trial showed that tranexamic acid, compared to placebo, reduced the risk of 77 
death from PPH by 20%.13 The trial faced an important challenge in terms of consent, as the 78 
treatment being studied needed to be given at the time women were experiencing a PPH. 79 
The trial design included a range of consent approaches, depending on the woman’s 80 
condition (see figure 1). Consent was obtained from women if their physical and mental 81 
capacity allowed (as judged by the treating clinician). If a woman was unable to give 82 
consent, proxy consent was obtained from a relative or representative. If a proxy was 83 
unavailable or unable to consent, consent was deferred and the woman was informed about 84 
the trial as soon as possible, written consent was requested later for data collection. Trial 85 
procedures were compliant with international guidelines and legislative frameworks relating 86 
to consent to emergency research.13-18 The UK Clinical Trials Regulations Amendment 2 19 87 
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and the updated Declaration of Helsinki 20.  In the UK, 569 women were randomised at 88 
seven maternity facilities. 506 of the 569 women were randomised without prior written 89 
consent and 501 women gave retrospective written consent to continue. 90 
 91 
This study aimed to investigate the views of a cohort of the participants in the WOMAN Trial 92 
to identify preferred method(s) of consent, assess the acceptability of waiver of prior consent 93 
and inform future guidance.  94 
 95 
Methods   96 
The study is reported following the consolidated criteria for reporting qualitative research 97 
(COREQ) guidelines.21 An interpretative qualitative methodology using in depth interviews 98 
was used to investigate women’s views.  99 
 100 
Participants were recruited from the UK site where the highest number of WOMAN Trial 101 
participants  were recruited (n=129/569). Purposive sampling ensured maximum variation of 102 
interviewees based on the method of consent used. 22 (Figure 2). Forty potential participants 103 
were identified from the randomisation log. Sixteen gave consent while their PPH was 104 
ongoing. Two had prior consent waived and subsequently declined to give written consent.  105 
There were 111 women who had consent waived and gave consent subsequently. Every 106 
fifth woman was invited, this ensured representation across the Trial’s duration (n=22). 107 
Written consent by relatives at the time of the emergency was not obtained for any of the 108 
participants. Trial recruitment occurred at the site between October 2011 and July 2013. This 109 
study was conducted once recruitment to the WOMAN Trial in the UK was completed and 110 
international recruitment remained ongoing. Interviews commenced following ethical 111 
approval in March 2015, with the intention that the findings would be available soon after the 112 
results of the WOMAN Trial were available.  113 
  
 
 
7 
 
 114 
Women were sent an Invitation and Information Sheet, then contacted by telephone. There 115 
were opportunities to ask questions prior to written consent. Interviews were audio-recorded 116 
and conducted using an interview schedule (see Appendix S1). All participants preferred to 117 
be interviewed at home. Family members and children were present during some . Data 118 
saturation was reached after fifteen interviews and evidenced during the final interviews and 119 
confirmed during initial coding. Participants consented to information collection from their 120 
records (see Table 1).  121 
 122 
Interviews were transcribed verbatim to create transcripts for thematic network analysis.23 123 
This method has parallels with the basic components of grounded theory, which organises 124 
data into concepts, categories and propositions. GH and CK undertook the analysis. In stage 125 
one; following data familiarisation, a coding framework was devised, first independently, and 126 
then agreed by consensus. MAXQDA11 was used to dissect the text into coded segments. 127 
Four a priori codes were assigned and 19 were grounded in the data (Appendix S2). GH and 128 
CK then abstracted and refined themes from coded segments, arranging them into nine 129 
basic themes and three organising themes, from which the global theme was deduced. The 130 
initial thematic network was verified and refined by constant comparative reflection and 131 
discussion. In stage two, GH and CK described and explored the thematic networks further, 132 
before summarising them. In stage three, GH and CK brought the network summaries 133 
together with existing theories, original research questions and the interests underpinning 134 
them. Figure 3 was produced in this final stage.  135 
 136 
GH and MD are practicing midwives. CK is a sociologist and maternity researcher. ZA is an 137 
obstetrician and researcher. GH, MD and ZA were collaborators in the WOMAN Trial. HS 138 
was lead investigator in the WOMAN Trial.  The ethical dilemmas raised by the 139 
unprecedented use of the waiver of prior consent provided the impetus for this study. 140 
  
 
 
8 
 
Although there was nothing to suggest that women were concerned about the consent 141 
processes used in the Trial in terms of complaints and declining continuation, the research 142 
team were reluctant to assume this equated to unanimous acceptance. GH, CK and MD 143 
conducted the interviews. As GH and MD were responsible for recruitment to the WOMAN 144 
trial, trial logs were checked to ensure GH and MD did not approach or interview women 145 
they had met in Trial activities.  146 
 147 
Results   148 
Fifteen women participated; eight gave consent to participate in the WOMAN trial while their 149 
PPH was on-going; for seven consent was waived (including one of two women who 150 
declined written consent retrospectively). The study algorithm and sample characteristics are 151 
illustrated in Figure 2. Table 1 reports demographic and clinical characteristics. Figure 3 152 
outlines the thematic structure of the  findings. Interviews lasted 20 minutes to 1½ hours. All  153 
transcripts conveyed the global theme “humane choreography of clinical, emotional and 154 
ethical considerations when negotiating consent to research”, underpinned by the three 155 
organising themes (i) Too much to process; (ii) Quality of relationships; and (iii) Making it 156 
right. Figure 3 illustrates the interconnectivity between themes.  157 
   158 
 159 
Theme 1 Women’s experiences: Too much to process 160 
Thirteen of the fifteen women experienced labour, two had an elective caesarean section; 161 
fourteen gave birth to a live baby. Women explained how their ability to process information 162 
and make decisions was compromised by having just given birth and experiencing a 163 
potentially life-threating event. A series of undistinguishable interactions with professionals 164 
were described. All women who signed a consent form around the time of Trial entry recalled 165 
being spoken to by professionals who were concerned about bleeding. However, none could 166 
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remember clearly which conversations related to clinical care and which were about 167 
research: “I think he [the Doctor] explained that it was a trial to do with stemming blood loss, 168 
but that was all a bit hazy. I was sobbing. I actually remember saying am I going to die? I 169 
didn’t really know at the time what I was saying yes to” (C13). 170 
 171 
As expected, the consent waiver was used most commonly when a woman’s consciousness 172 
was affected. This meant some women remembered very little. Six participants signed 173 
consent for continued participation in the hours or days after recruitment. Few recalled these 174 
discussions or signing the form. Some recalled more when prompted.  175 
 176 
“Can you remember talking to anybody about taking part in any research?”  177 
“No.”  178 
“Not at all?”  179 
“I can’t remember that at all.”  180 
The interviewer then showed the ‘Alert Card’ given to all WOMAN Trial participants  181 
 “So this is the research that you took part in?” 182 
“Oh. Right, OK. I have got one of these.”  183 
Long pause. “So I have been involved in it then haven’t I?” (W13).  184 
 185 
Although we expected the consent waiver to be used when a woman’s consciousness was 186 
impaired, we did not anticipate how similar the interviews with women recruited using the 187 
three methods would be. Six women lost consciousness, many more described an altered 188 
state of consciousness where they were unable to think or remember clearly.  189 
 190 
Views on providing information and obtaining informed written consent to research at the 191 
time of an emergency varied from hypothetically desirable to an inappropriate 192 
inconvenience. All women understood the need for prompt action and how delays could 193 
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compromise any possible benefit the research may offer. One who gave prior consent said 194 
“They could have given me a piece of paper to say I was signing my mortgage away. The 195 
signing thing, it’s just it seems quite pointless really” (C08). A woman, for whom the consent 196 
waiver was used, said “You couldn’t discuss something like that at that point. It had to be 197 
done by someone else” (W02). Another from the waiver group stressed the immediacy of the 198 
intervention: “I think you should go ahead if you think it is going to help” (W16). All but one 199 
participant recruited using the consent waiver of felt the process was acceptable. Her 200 
consciousness appears to have been affected very briefly and she felt there were missed 201 
opportunities for discussion.  202 
Amongst women who provided written consent, some were initially shocked to learn others 203 
had been entered into the Trial without; “I don’t think I would have been happy.” (C04). 204 
Others disagreed; “I think when you are in a critical situation, conscious or not, I’d have been 205 
happy for them to waiver consent” (C09). The woman who declined to sign a consent form 206 
retrospectively was not negative “It needs to be done there and then. Just to go straight to it, 207 
in case any more damage happens” (D02). Her reason for not signing was related to early 208 
hospital discharge.  209 
Women’s ability to process information was affected at the time of trial entry and in the days 210 
and weeks afterwards. Women were asked if they looked at Trial information later: “Not 211 
really, you get given all these things, the pack, little red book and you have got this baby in 212 
your arms. When I get five minutes to myself I will read the leaflets” (W16). Overall, women 213 
appeared to have little capacity for research activities in their life-changed, post-birth, post-214 
PPH, world, for most, the invitation to participate in this study was the first time they had 215 
found time to give the WOMAN Trial a thought.  216 
 217 
Tables  S1, S2 and S3 provide more quotes to support the three organising themes. 218 
  219 
Theme 2 Women’s views: Quality of relationships 220 
  
 
 
11 
 
With one exception, interviewees demonstrated immense trust in professional expertise. The 221 
degree of trust reflected participant’s perceptions of the quality of the relationships that 222 
developed within clinical scenarios. Many recalled interactions where trust and respect was 223 
built or lost. “I remember these two (doctors) being really excited about the trial.  I remember 224 
a senior doctor telling them off. I mostly felt at that time that (wife) was a bit of a guinea pig . 225 
(Partner of C08). 226 
 227 
Participants understood the challenges associated with conducting research during 228 
emergencies, and were happy for the obstetrician to carry this burden. Participants appeared 229 
to understand that a placebo was used, interestingly many firmly believed their clinical 230 
situation had been improved by the Trial medication . “In my eyes it worked. Whether it was 231 
water, medication, orange juice, whatever,” (W01). 232 
 233 
The woman who was not satisfied felt by her doctor failed to acknowledge  her previous 234 
experiences of motherhood; “The placenta got stuck. I said to her (Doctor) it’s stuck and she 235 
said no it’s not. I said it is. This is number 3 not number 1.  (W22). Women’s views on 236 
whether their birth partner should be involved in decision-making varied, some recognised 237 
how this might be compromised by their own birth experience “I think they would be in a 238 
state at the time” (C05). Partner’s involvement was viewed as a courtesy rather than a 239 
necessity. 240 
 241 
Theme 3 Women’s needs: Making it right  242 
While most participants were “fine” with the recruitment process, many suggested 243 
improvements. During the WOMAN Trial a brief information leaflet was provided in clinics. 244 
Increasing opportunities for giving information was important; obtaining a signature on a form 245 
was not. Women articulated the difficulties clinicians face in providing balanced information 246 
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during pregnancy and labour “I suppose do you wanna scare people by telling them all the 247 
things that could go wrong? C08. Most women felt an individualised approach was best, the 248 
complexity of doing this well was acknowledged “I don’t know whether there is a right way. 249 
You’ve just got to do what you can in the situation at that time” W02.   250 
Providing explanations and answering questions at an appropriate time were crucial. 251 
Professional awareness of the impact childbirth, particularly a traumatic experience, can have 252 
upon cognitive ability was critical. “They could’ve come the day after when I was more alert, 253 
more aware and I didn’t have 20 people coming in and out” W02.  C04 initially appeared 254 
against the idea of retrospective consent, however on reflection, she describes how the 255 
explanation was all important. “Because it was explained properly, you go, well I accept that 256 
and thanks for taking the time to go into it and you know sort of do the right thing.”  257 
Many women expressed a positive view of research and verbalised altruism towards other 258 
women and society “I think it’s a very good idea because how else are we meant to learn for 259 
other people for the future, W01. 260 
Not missing opportunities for research was also important:   261 
“It doesn’t mean that should you come across a lady in my situation at the time the 262 
emergency is going on that you can’t ask her.”  263 
 (C04) 264 
 265 
The global theme humane choreography of consent to research (“how it’s done”) 266 
encapsulates what really mattered. How consent was negotiated was judged by perceptions 267 
of respect and the quality of human interactions during care. Women expected every 268 
reasonable effort to be made to communicate with them; they appreciated why this was not 269 
always easy or achievable. From what first appeared as indistinguishable fragmented 270 
memories of giving birth, receiving treatment for PPH and being approached regarding 271 
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research, emerged the proposition that doing consent well involves a skilful balance and co-272 
ordinatiion of important aspects amidst a plethora of human emotions. This evoked the 273 
metaphor of a complex dance, dynamic and humanely choreographed when done well; 274 
chaotic and disrespectful when not. 275 
 276 
Discussion  277 
Main findings  278 
Participants favoured no particular WOMAN Trial consent procedure; instead they valued a 279 
humane choreography of informed consent appropriate to their personal situation. This does 280 
not run contrary to the principles in the Declaration of Helsinki or more recent policy 281 
statements that highlight the importance of high-quality respectful, humanised care.20,24 282 
Women completely understood the complexity of issues at play and the associated 283 
challenges associated with consent. Participants were less concerned with procedures and 284 
paperwork and more concerned with the quality of human interactions. This was indicative of 285 
feeling professionals had done the right thing at a time when a decision could not be made 286 
fully by the woman herself. The WOMAN Trial research protocol acknowledged how the 287 
differing clinical scenarios of PPH and the clinical status of a woman would determine the 288 
consent procedure used. It was an unanticipated finding of this study just how similar 289 
participants’ experiences would be; irrespective of the severity of their PPH or consent 290 
procedure used. 291 
    292 
 293 
Strengths and limitations   294 
This is the first study of the views of women who have  experienced being included in a RCT 295 
of treatment for an obstetric emergency trial where a waiver of consent was used. A key 296 
strength of this study is that it included women who gave their written consent prior to entry 297 
into the Trial and women where prior consent was waived. Opportunities to purposively 298 
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sample women who declined were limited. Only women who took part in the WOMAN trial 299 
from one UK site were included in this study, including women from other sites may have 300 
resulted in more varied responses. As many of the women interviewed for this study did not 301 
remember the WOMAN Trial, there was a need for to explain what had actually happened. 302 
Views expressed at interview may therefore have been influenced by the short time 303 
participants had to consider their feelings and thoughts. The interviews took place one year 304 
or more after participants were included in the WOMAN trial.  Although existing research 305 
suggests that in the long term (1 year or more) women usually describe aspects of their 306 
labours and birth consistently,26 the effect of this time lapse on participants in this particular 307 
study is unknown.  308 
   309 
Interpretation   310 
Conducting emergency obstetric care trials to improve outcomes for women and negotiating 311 
consent to research in this emergency situation is a necessary component of medical care. 312 
Clinical trials are governed by European Legislation, which set the  framework for valid 313 
informed consent as the cornerstone of experimental research involving human beings.18 314 
The European Directives made no provision for consent in critical emergency situations. In 315 
2008, UK legislation was introduced to enable researchers to seek consent after a person 316 
had been given an investigational drug or device when the following conditions are met: 317 
“(i) treatment is required urgently; (ii) urgent action is required for the purposes of the trial; 318 
(iii) it is not reasonably practicable to obtain consent prospectively; and (iv) an ethics 319 
committee has given approval to the procedure under which the action is taken.” 7 However, 320 
some clinicians remain very uncomfortable deferring written consent.12 321 
All women in this study could not recall detail of their involvement in the WOMAN Trial. Most 322 
were largely unaware they had been part of a research study, until approached to participate 323 
in this study. This is similar to the experiences of parents whose children were entered into 324 
emergency research27 and existing studies of women’s experiences of PPH.28 This loss of 325 
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memory may, in part, reflect the response of the brain to perceived trauma.29 This recurrent 326 
finding does however raise an important question about the meaningfulness of informed 327 
consent in any spheres of clinical practice where psychological trauma may occur. Akkad et 328 
al.30 proposed that truly informed consent may be impossible to achieve within the context of 329 
clinical emergencies. Some of the women included in this study agree, viewing discussing 330 
consent at such a time as “pointless.” Snowden et al, asked women to consider 331 
hypothetically what they would do in this situation.11 Interviewees rejected decision-making 332 
prior to delivery, and by their partners/representative at the time of the emergency. Preferred 333 
options were antenatal decisions, followed by doctors making decisions at the time of the 334 
emergency. The views of women considering the hypothetical situation were, to an extent, 335 
supported in this study.  336 
The principles of informed consent were of utmost importance, at the same time, women 337 
accepted the complexity of when, how, and by whom this is achievable. Vernon, Alfirevic 338 
and Weeks1 previously described a pathway for consent that acknowledged the importance 339 
of considering women’s individual situations. These findings go further in explaining why a 340 
‘one size fits all’ consent process is inadequate. What is important is not so much the 341 
process, but the way in which it is undertaken. Hinton et al’s study 31 of near-miss maternal 342 
morbidities supports the importance of the “little things” (personal touches, flexibility, taking 343 
time to explain) in helping women make sense of complex situations and improving 344 
perceptions of care.  345 
 346 
The conduct of the WOMAN Trial did not result in complaints; the absence of complaint is 347 
however a poor measure of acceptability. These findings offer detailed insight that can be 348 
used by researchers planning similar studies. Multiple pathways to consent, when used 349 
appropriately within a range of clinical scenarios, rather than waiver of consent waiver per 350 
se, appear to be acceptable.  The women in this study clearly articulated why complacency 351 
is unacceptable and that efforts to improve consent processes should focus on the quality of 352 
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human interactions, increasing opportunities to communicate courtesy and impart 353 
information.  354 
  355 
Conclusion  356 
 357 
The consent procedure in the WOMAN Trial utilised a variety of approaches dependent on 358 
the clinical scenario. Overall all the consent procedures were acceptable, with no difference 359 
in the views of women who gave consent and those where consent was deferred.. The 360 
current study has shown that professional concerns appear largely unfounded, Interviews 361 
illustrated that women remember very little of the emergency or the research. Women 362 
understood that obtaining consent to research in an emergency is complex and they 363 
appreciated an approach which took their own personal situation into consideration. Care 364 
must be taken not to interpret this as consent is unimportant. linicians need to recognise the 365 
importance of a humane choreography of clinical, ethical and emotional considerations and 366 
should focus on developing skills in respectfully obtaining consent in partnership with women 367 
and their families. Professionals could develop skills by practising research recruitment 368 
alongside scenario based emergency drills. It is essential that those responsible in designing 369 
future research trials acknowledge the views of these women.  370 
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